Horizon Technology Finance Corporation (HRZN) is a business development company (BDC) that makes secured loans to venture capital-backed technology and life-science firms. With shares trading near $4.07 and the most recent analyst price targets averaging roughly $5.00, investors are asking whether a roughly 23% advance is plausible.
Six recent, individually attributable price targets form the basis for the $5.00 figure. BTIG holds at $4.50, Keefe, Bruyette & Woods is at $4.50 after trimming from $5, UBS is at $4.50, and Oppenheimer is at $5.00; Compass Point initiated at $5.50 with a Buy, while Maxim Group carries the high target of $6.00. The mean of these six figures is $5.00, with a low-to-high range of $4.50 to $6.00.
The range is unusually wide for a sub-$5 stock, reflecting genuine disagreement about credit quality and earnings power rather than a clean consensus. Bulls argue the shares are cheap relative to NAV and income potential; cautious analysts emphasize distribution coverage and portfolio risk. The prevailing rating remains a Hold, and no analyst projects a return to the 52-week high near $6.85.
HRZN last traded around $4.07, near the lower end of a 52-week range of $3.80 to $6.85. Reaching $5.00 implies a gain of roughly 23%, which is substantial rather than modest. The path would likely depend on third-quarter results, scheduled for November 5, 2026, and on continued net investment income (NII) sufficient to cover its $0.06 monthly base distribution plus the recently added $0.03 special distribution.
Horizon merged with Monroe Capital in April 2026 and now operates as an affiliate of Monroe Capital, giving it a larger balance sheet and an expanded venture-debt platform. Its debt portfolio yielded about 14.9% in the second quarter of 2026. The stock trades at roughly 0.66 times its reported NAV of about $6.23, meaning investors are buying the portfolio at a meaningful discount to book value.
HRZN has spent much of the period below its 52-week high of $6.85, with support near the $3.80–$4.00 zone where the stock found buyers. The $5.00 level itself acts as a psychological and analytical resistance point, sitting just above the cluster of $4.50 targets. A sustained move above $5.00 would need to clear that zone, with the $6.00 area representing the next notable ceiling. Until the stock reclaims levels above its recent range, the longer-term trend structure remains sideways to lower.
Analyst price targets typically reflect a research horizon of around 12 months, though individual firms may differ. The most important near-term catalyst is the November 5, 2026 earnings release, where investors should watch NII per share, NAV, distribution coverage, and any new non-accruals or write-downs. Beyond earnings, monitor Federal Reserve rate policy, venture-funding conditions, portfolio yield trends, and any changes to the monthly or special distributions.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to surface new opportunities, keep an eye on existing positions, and identify changing trends more efficiently than manual scanning allows. For those tracking income-oriented names like HRZN alongside growth and momentum plays, the tool offers a way to stay current without watching every chart manually.
The $5.00 central target is the average of six current analyst price targets spanning $4.50 to $6.00, and it sits about 23% above the latest price near $4.07. The strongest supports are a high-yield secured portfolio, a discount to NAV, and a steady monthly payout, while the principal obstacles are distribution-coverage shortfalls, credit write-downs, and a cautious analyst stance. Reaching the target would require improved NII coverage and greater confidence in credit quality rather than a simple valuation re-rating. Investors should watch the November earnings report and NAV trends as the clearest indicators of whether that scenario develops.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HRZN has been loosely correlated with NEWT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HRZN jumps, then NEWT could also see price increases.
| Ticker / NAME | Correlation To HRZN | 1D Price Change % | ||
|---|---|---|---|---|
| HRZN | 100% | -1.45% | ||
| NEWT - HRZN | 46% Loosely correlated | -2.27% | ||
| BBDC - HRZN | 44% Loosely correlated | -0.69% | ||
| PFLT - HRZN | 36% Loosely correlated | -0.86% | ||
| ARCC - HRZN | 36% Loosely correlated | -0.05% | ||
| BXSL - HRZN | 34% Loosely correlated | -0.98% | ||
More | ||||